Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityActive in the last 2 years

Can Xu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5112306591. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. SiATG5-loaded cancer cell membrane-fused liposomes induced increased uptake of albumin-bound chemotherapeutics by pancreatic cancer cells. Co-author DOI 10.1016/j.jconrel.2024.01.055↗
  2. Viral therapy for pancreatic cancer: tackle the bad guys with poison. Co-author DOI 10.1016/j.canlet.2013.01.035↗
  3. CEA promoter-regulated oncolytic adenovirus-mediated Hsp70 expression in immune gene therapy for pancreatic cancer. Co-author DOI 10.1016/j.canlet.2012.01.009↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jing Yan · 1 shared paper, 2024 · strength 0.20
  2. Yan Wei · 1 shared paper, 2024 · strength 0.20
  3. Zhao‐Shen Li · 2 shared papers, 2012–2013 · strength 0.08
  4. Changqing Su · 2 shared papers, 2012–2013 · strength 0.08
  5. Yunliang Sun · 1 shared paper, 2012 · strength 0.03
  6. Yan Yan · 1 shared paper, 2012 · strength 0.03
  7. Maoling Zhu · 1 shared paper, 2012 · strength 0.03
  8. Lei Chen · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.